Medi First R&D collaborates with hospitals, universities, and industry partners on program-specific profiles, formulations, and evidence pathways.
For us, collaboration is a methodological process: we bring clinical questions, development, and evidence together so that projects remain comparable and compatible with existing care and research structures. At the center is joint work on profiles that can be standardized, dosed, and evaluated.
Submit a collaboration inquiry
Note: Information and documents are provided on a project basis and subject to review (possibly NDA-based).
Collaboration on equal terms
We understand collaboration as a complementary approach: clinical objectives, methodological criteria, and evidence formats are defined jointly so that results are directly actionable.
Universities & institutes
Joint research questions, method development, and validation - depending on the project format, including analysis and transfer logic.
Hospitals & medical institutions
Protocol design, indication-close observational formats, and incorporation of anonymized real-world outcomes (GDPR-compliant) into hypothesis generation and safety monitoring.
Industry & pharma partners
Co-development along Target Product Profiles (TPP), formulation development, and delivery options to support standardization and clinical applicability.
Collaboration models
Our collaboration is modular. We engage where your project stands and jointly define what makes sense next.
01 Contract research (contract research)
Targeted development and characterization of chemovars as well as formulation work along defined target parameters.
Focus areas: bioavailability, stability, profile design.
02 Joint studies & evidence partnerships
Joint design and implementation of suitable evidence formats (e.g., non-interventional studies/observational use studies, RWD/RWE analyses) along defined endpoints and protocol logic.
Focus areas: data integrity, safety monitoring, endpoint definition.
03 Strategic co-development
Partnership along the entire development chain: from TPP definition through prototyping to evidence generation and (project-dependent) implementation logic in the care setting.
Schwerpunkt: iterative validation loops and transparent decision criteria.
Governance & confidentiality
Robust evidence needs clear rules. Data protection, data integrity, and confidentiality are integral to every collaboration. Data collection is GDPR-compliant and anonymized (where required). Detailed information and documents are governed on a project basis. Confidentiality can be secured via an NDA framework.
Collaboration inquiry
For an initial exchange, a brief description of your question is sufficient (see “Recommended information”). We will get back to you with follow-up questions and propose a suitable collaboration format. Detailed information and documents will be aligned on a project basis.
Recommended information:
Organization · Contact person/role · Question/project focus · desired evidence format (optional) · time horizon · NDA desired (Yes/No)
Send collaboration inquiry now
Note: Information on this website is intended for professional and collaboration partners. No medical advice and no individual therapy recommendations.
